Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical…
China, ASEAN and GCC Advance Cooperative Frameworks to Strengthen Regional Supply Chain Resilience
KUALA LUMPUR, Malaysia, May 29, 2025 /PRNewswire/ -- China, the Association of Southeast…
